Le Pechoux, C., Pourel, N., Barlesi, F., Lerouge, D., Antoni, D., Lamezec, B., Nestle, U., Boisselier, P., Dansin, E., Paumier, A., Peignaux, K., Thillays, F., Zalcman, G., Madelaine, J., Pichon, E., Larrouy, A., Lavole, A., Argo-Leignel, D., Derollez, M., Faivre-Finn, C., Hatton, M. Q., Riesterer, O., Bouvier-Morel, E., Dunant, A., Edwards, J. G., Thomas, P. A., Mercier, O., & Bardet, A. (2022). postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial. Lancet oncology, 23(1), 104–114. http://access.bl.uk/ark:/81055/vdc_100148173543.0x00000c